Mr Daniel Harris
Swansea University, Swansea (United Kingdom of Great Britain & Northern Ireland)
Early discontinuation of P2Y12 antagonist and adverse clinical outcomes post percutaneous coronary intervention
Event: EuroPrevent 2018
Topic: Coronary Artery Disease, Other
Session: Coronary artery disease, acute coronary syndromes, acute cardiac care
ESC 365 is supported by
